H5N1 Vaccine

Avian influenza viruses, particularly the H5 and H7 subtypes, can cause widespread outbreaks in birds and pose a significant zoonotic risk due to their potential to mutate and develop the ability for human-to-human transmission. Researchers from the University of Muenster described the preclinical efficacy of zapnometinib, a selective MEK1/2 inhibitor, against H5N1 clade 2.3.4.4b.

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

La Trobe scientists find Killer T cells could protect against bird flu

Scientists at La Trobe University have identified a possible defense for humans against the influenza virus H5N1—commonly known as "bird flu"—which could open avenues of research for new vaccine development.

Launching this month, Vaxitek HVT+IBD+H5 integrates COBRA technology to address the ongoing viral evolution challenges of avian influenza, as well as for the prevention of Marek disease and infectious bursal disease.

A unique European research project aims to protect zoo birds from bird flu. Bern Animal Park, Basel Zoo and the Institute of Virology and Immunology (IVI) are working together to test a promising, innovative vaccine that effectively protects endangered wild bird species kept in zoos.

LSU Vet Professor weighs in on potential poultry vaccine for bird flu

Agriculture Secretary Brooke Rollins is expected “in the coming days” to announce a new strategy to fight the escalating outbreak.

India's apex health research body has warned that H5N1 infection in humans has a high case fatality rate, exceeding 50 percent.

Valid as of February 19, 2025: The National Advisory Committee on Immunization's rapid response related to preliminary guidance on human vaccination against avian influenza in a non-pandemic context as of December 2024.

Genome BC is funding a set of research projects to address the risk associated with a strain of avian influenza, of the H5N1 subtype. The BCCDC is conducting...

Field studies led by Wageningen University have demonstrated the efficacy of two vaccines in reducing mortality in poultry infected with the Highly Pathogenic Avian Influenza (HPAI) H1N1 virus, although it is too early to draw accurate conclusions about transmission.

Canada's public health agency says this comes as a protective measure as bird flu cases, which can potentially spread between people, continue to rise.

A bird flu vaccination campaign launched in France in 2023 has enabled the country's poultry production to recover to levels not seen since outbreaks of the virus wiped out tens of millions of birds, producers said on Tuesday.

As more people are hospitalized with bird flu, here's what's going on with vaccines for humans.

With winter on its way in New Zealand, an immunologist is warning there could be higher levels of influenza going around in the months ahead, and is suggesting a broad...

The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the animal healthcare company said on Friday.

The decision brings U.S. poultry farmers a step closer to immunizing their flocks

Senator from New Mexico makes the case for poultry vaccination to agriculture secretary nominee, who has yet to share an opinion for or against vaccines.

NanoViricides (NYSE-A:NNVC) stated today that it is prepared to address the escalating threat of bird flu with its broad-spectrum antiviral drug, NV-387....

Scientific Reports - Evaluation of humoral immune response and milk antibody transfer in calves and lactating cows vaccinated with inactivated H5 avian influenza vaccine

Clinical data shows Ampligen boosts FluMist efficacy 4-fold against avian flu strains, with 50-100% survival rates in preclinical studies. Human trials confirm safety.

Mangoceuticals advances in H1N1 and H5N1 studies

Other countries are using a bird flu vaccine successfully in poultry and that if we vaccinate the poulets (the young birds) today.

The ICMR has initiated the process of development of an ingenious human vaccine candidate against highly-pathogenic avian influenza (H5N1).

The World Health Organization (WHO) estimates that seasonal influenza causes 3-5 million cases of severe illness annually. The influenza virus frequently undergoes genetic changes through antigenic drift and antigenic shift, resulting in annual epidemics and occasional pandemics. Consequently, a maj …

Faculty are working on a vaccine for the H5N1 virus, studying its transmission, and helping the state test samples from birds and mammals.